Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.27 Insider Own41.32% Shs Outstand8.48M Perf Week-4.81%
Market Cap52.29M Forward P/E- EPS next Y-2.85 Insider Trans0.00% Shs Float7.05M Perf Month-12.65%
Income-44.17M PEG- EPS next Q-4.80 Inst Own9.06% Short Float / Ratio0.45% / 4.78 Perf Quarter-46.45%
Sales80.58M P/S0.65 EPS this Y-373.45% Inst Trans- Short Interest0.03M Perf Half Y-67.05%
Book/sh18.67 P/B0.23 EPS next Y86.52% ROA-13.24% Target Price10.00 Perf Year-84.15%
Cash/sh7.06 P/C0.62 EPS next 5Y- ROE-16.74% 52W Range3.84 - 46.05 Perf YTD-85.50%
Dividend- P/FCF- EPS past 5Y- ROI-19.41% 52W High-90.55% Beta-0.35
Dividend %- Quick Ratio2.32 Sales past 5Y-0.03% Gross Margin47.96% 52W Low13.28% ATR0.50
Employees397 Current Ratio2.40 Sales Q/Q-93.89% Oper. Margin-43.96% RSI (14)34.81 Volatility6.89% 12.06%
OptionableNo Debt/Eq0.02 EPS Q/Q63.61% Profit Margin-54.81% Rel Volume0.44 Prev Close4.20
ShortableYes LT Debt/Eq0.01 EarningsNov 20 BMO Payout- Avg Volume6.61K Price4.35
Recom1.00 SMA20-9.87% SMA50-25.47% SMA200-58.93% Volume2,900 Change3.57%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Nov-20-23 06:00AM
Nov-01-23 06:00AM
Sep-15-23 07:10AM
Aug-29-23 12:46AM
Jun-30-23 08:00AM
09:30AM Loading…
Jun-26-23 09:30AM
Jun-25-23 08:45PM
Jun-05-23 07:20AM
Mar-14-23 08:56AM
Mar-02-23 07:00AM
Feb-02-23 04:01PM
Jan-19-23 05:00AM
Jan-17-23 10:00AM
Jan-10-23 08:05AM
Dec-16-22 06:27AM
09:15AM Loading…
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
Aug-12-22 09:34AM
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
May-23-22 12:00PM
May-19-22 12:15PM
May-18-22 06:30PM
May-17-22 11:00AM
Prenetics Global Ltd. engages in the provision of preventive and diagnostic health testing and services. It operates through the following segments: Prevention, Diagnostics, and Personalized Care. The Prevention segment delivers genetic testing services to individuals and corporate entities. The Diagnostics segment includes COVID-19 testing services for individuals, corporate clients, and governments for community testing. The Personalized Care segment offers personalized nutrition, hair loss, and sexual health products tailored to each of customer's individual and genetic variation and biology. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.